It was previously demonstrated that the up-regulation of Meflin (immunoglobulin superfamily containing leucine-rich repeat) expression confers a tumor-restraining role on CAFs in pancreatic, colon, urothelial, and lung cancers. This evidence concerns the gene ISLR and neoplasm.